鏉变簽鑳冭吀钘
Kraj: Tajwan
J臋zyk: chi艅ski
殴r贸d艂o: 琛涚敓绂忓埄閮ㄩ鍝佽棩鐗╃鐞嗙讲 (Ministry of Health and Welfare, Food And Drug Administration)
Wys艂a膰 pro艣b臋.
Sk艂adnik aktywny:
MAGNESIUM CARBONATE HEAVY;;CALCIUM CARBONATE;;ALUMINUM MAGNESIUM SILICATE;;SCOPOLIA EXTRACT;;FENNEL (FOENICULUM);;CINNAMON (CINNAMON CORTEX ) (CINNAMON BARK);;AMOMI;;SWERTIA;;CLOVE;;DIASTASE ASPERGILLUS ORYZAE(DIASTASE TAKA);;GLYCYRRHIZA (LIQUORICE)
Dost臋pny od:
楂樺師璨挎槗鏈夐檺鍏徃 鍙板寳宸垮欢骞冲寳璺竴娈碉紥锛撹櫉 (07330408)
Forma farmaceutyczna:
鏁ｅ姂
Sk艂ad:
SCOPOLIA EXTRACT (1208004502) (DIL *3) 30MG; DIASTASE ASPERGILLUS ORYZAE(DIASTASE TAKA) (4400002100) (T) 50MG; ALUMINUM MAGNESIUM SILICATE (5604000500) 400MG; CALCIUM CARBONATE (5604001200) (PPT) 250MG; MAGNESIUM CARBONATE HEAVY (5604002406) 100MG; CINNAMON (CINNAMON CORTEX ) (CINNAMON BARK) (5610000100) 100MG; FENNEL (FOENICULUM) (5610000300) 10MG; CLOVE (7200000300) 10MG; GLYCYRRHIZA (LIQUORICE) (9200004400) 50MG; AMOMI (9200014800) 33.33MG; SWERTIA (9200014900) 1.67MG
Sztuk w opakowaniu:
琚嬭
Klasa:
瑁姐鍔
Typ recepty:
闋堢敱閱斧铏曟柟浣跨敤
Wyprodukowano przez:
TOA YAKUHIN CO. LTD. NO.26, SANGO, TOYAMA-CITY JP
Wskazania:
娑堝寲涓嶈壇銆佽儍閰搁亷澶氥佽吀鍏х暟甯搁啽閰点佽儍鐥
Podsumowanie produktu:
瑷婚姺鏃ユ湡: 2000/10/20; 瑷婚姺鐞嗙敱: 鏈睍寤惰岄炬湡鑰; 鏈夋晥鏃ユ湡: 1998/06/16; 鑻辨枃鍝佸悕: TOA STOMACHIC MEDICINES
Status autoryzacji:
宸茶ɑ閵
Data autoryzacji:
1985-03-05
